Cargando…

Regulation of B Cell Responses in SLE by Three Classes of Interferons

There are three classes of interferons (type 1, 2, and 3) that can contribute to the development and maintenance of various autoimmune diseases, including systemic lupus erythematosus (SLE). Each class of interferons promotes the generation of autoreactive B cells and SLE-associated autoantibodies b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domeier, Phillip P., Rahman, Ziaur S. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508684/ https://www.ncbi.nlm.nih.gov/pubmed/34638804 http://dx.doi.org/10.3390/ijms221910464

Ejemplares similares

miRNA-Mediated Control of B Cell Responses in Immunity and SLE
por: Schell, Stephanie L., et al.
Publicado: (2021)

B-Cell-Intrinsic Type 1 Interferon Signaling Is Crucial for Loss of Tolerance and the Development of Autoreactive B Cells
por: Domeier, Phillip P., et al.
Publicado: (2018)

TLR7 Negatively Regulates B10 Cells Predominantly in an IFNγ Signaling Dependent Manner
por: Chodisetti, Sathi Babu, et al.
Publicado: (2020)

Cause and consequences of the activated type I interferon system in SLE
por: Eloranta, Maija-Leena, et al.
Publicado: (2016)

Interferon pathway in SLE: one key to unlocking the mystery of the disease
por: Rönnblom, Lars, et al.
Publicado: (2019)

Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway
por: Oon, Shereen, et al.
Publicado: (2016)

Mechanisms of B cell autoimmunity in SLE
por: Dörner, Thomas, et al.
Publicado: (2011)

Interferon Genes Are Influenced by 17β-Estradiol in SLE
por: Singh, Ram P., et al.
Publicado: (2021)

Uncoupling interferons and the interferon signature explain clinical and transcriptional subsets in SLE
por: Gómez-Bañuelos, Eduardo, et al.
Publicado: (2023)

B Cell Tolerance and Targeted Therapies in SLE
por: Parodis, Ioannis, et al.
Publicado: (2023)

IFN-γ receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity
por: Domeier, Phillip P., et al.
Publicado: (2016)

Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients
por: Ko, Kichul, et al.
Publicado: (2013)

Case Report: Response of cutaneous lupus lesions in SLE to interferon receptor blockade parallels reduction of interferon score in blood
por: Günther, Claudia, et al.
Publicado: (2023)

CD52 Is Elevated on B cells of SLE Patients and Regulates B Cell Function
por: Bhamidipati, Kartik, et al.
Publicado: (2021)

SLE: reconciling heterogeneity
por: Lockshin, Michael D, et al.
Publicado: (2019)

SLE Peripheral Blood B Cell, T Cell and Myeloid Cell Transcriptomes Display Unique Profiles and Each Subset Contributes to the Interferon Signature
por: Becker, Amy M., et al.
Publicado: (2013)

Interplay of neutrophils and type I interferons in the development of end-organ damage in SLE
por: Kaplan, MJ
Publicado: (2012)

Aberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body Ecology
por: Reder, Anthony T., et al.
Publicado: (2013)

Cell-bound complement activation products in SLE
por: Ramsey-Goldman, Rosalind, et al.
Publicado: (2017)

BTLA Expression and Function Are Impaired on SLE B Cells
por: Wiedemann, Annika, et al.
Publicado: (2021)

Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases
por: Flint, Shaun M, et al.
Publicado: (2016)

B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design
por: Reddy, Venkat, et al.
Publicado: (2013)

Epigenetic programming underpins B cell dysfunction in human SLE
por: Scharer, Christopher D., et al.
Publicado: (2019)

Autoantibodies in SLE: Specificities, Isotypes and Receptors
por: Dema, Barbara, et al.
Publicado: (2016)

Dysregulation of immunity in COVID-19 and SLE
por: Hejazian, Seyyed Sina, et al.
Publicado: (2022)

B cells at the adaptive-innate immune system interface in SLE
por: Anolik, JH, et al.
Publicado: (2012)

B cell alterations during BAFF inhibition with belimumab in SLE
por: Ramsköld, Daniel, et al.
Publicado: (2018)

Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE
por: Casey, Kerry A, et al.
Publicado: (2018)

New Frontiers: ARID3a in SLE
por: Garton, Joshua, et al.
Publicado: (2019)

Age-Associated B Cells (ABCs) in the Prognosis, Diagnosis and Therapy of Systemic Lupus Erythematosus (SLE)
por: Sachinidis, Athanasios, et al.
Publicado: (2020)

IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE
por: Wang, Shu, et al.
Publicado: (2018)

SLE and APS
por: Avcin, Tadej
Publicado: (2014)

Epigenetics in SLE
por: Hedrich, Christian Michael
Publicado: (2017)

Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE
por: Kennedy, William P, et al.
Publicado: (2015)

Aggregation of MAVS antiviral protein suggests a mechanism for increased type I interferon production in SLE
por: Shao, Wen-Hai, et al.
Publicado: (2014)

Correction: Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE
Publicado: (2018)

Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE) †
por: Ponticelli, Claudio, et al.
Publicado: (2010)

The Influence of Diet and Obesity on Gene Expression in SLE
por: La Cava, Antonio
Publicado: (2019)

Principles behind SLE treatment with N-acetylcysteine
por: Nasr, Sandy, et al.
Publicado: (2022)

Involvement of Gut Microbiota in SLE and Lupus Nephritis
por: Mohd, Rozita, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cbc05p29vsjjt3g53okv9mus4g